Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News CASI Pharmaceuticals Inc CASI

Healthcare Biotechnology
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CASI)

CASI Pharmaceuticals Announces Third Quarter 2024 Business and Financial Results

Accesswire 11 days ago

CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia

Accesswire October 24, 2024

CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE

PR Newswire September 4, 2024

CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS

PR Newswire August 16, 2024

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

PR Newswire July 19, 2024

CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP

PR Newswire July 8, 2024

CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company

PR Newswire June 26, 2024

CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He

PR Newswire June 26, 2024

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)

PR Newswire May 15, 2024
View More News ››

Opinion & Analysis (NDAQ:CASI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CASI)

CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRI

JUST IN: $CASI CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCECASI PHARMACEUTICALS TO...
whytestocks - September 4, 2024

CASI Pharmaceuticals Faces Headwinds, but Promising Pipeline

http://beyondspx.com/2024/08/01/casi-pharmaceuticals-faces-headwinds-but-promising-pipeline-offers-hope/
MikeTester - August 1, 2024

CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Cli

News; $CASI CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients | BenzingaCASI...
whytestocks - March 5, 2024

I'm Out

Sold for some nice gains - going down
mpetit - June 6, 2009

I agree

Took are real dive and got in during year end sell off - lucky me
mpetit - May 18, 2009

Am I the only one holding

Not to much action here
mpetit - March 5, 2008
View more Bullboard ››

New Pacific Metals Corp.

New Pacific Metals Corp.

New Pacific Metals Corp. is a Canada-based exploration and development company, which is focused on three precious metal ...
View More »